Key facts
- Revive (Healthcare Technology Systems)’s last known valuation is $8.5M (Oct 2025).
- It has raised $1.2M; the latest was Seed Round ($1.2M) in Oct 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Revive (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Revive (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Revive (Healthcare Technology Systems)
Developer of health monitoring platform intended to help clients suffering from chronic pain. The company's platform offers remote health monitoring utilizing various wearable technologies, and genetic sequencing to develop individual health recommendations with the latest research in immunity, centred around evidence-based nutrition for pain management and optimization of health including mental health, immunity, gut, sleep and nutrition.
- Sector
- Healthcare
- HQ
- Bournemouth, United Kingdom
- Founded
- 2022
- Employees
- 8
- Website
- revivedna.com/
- Ownership
- Privately Held (backing)
Revive (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Revive (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Revive (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.